Similar articles

• [Dangers and potential uses of enzyme stimulating medication on newborns and infants].

  Windorfer A. Windorfer A. Padiatr Padol. 1972;7(3):246-52. Padiatr Padol. 1972. PMID: 5066482 German. No abstract available.
• The yellow baby.

  Catz C. Catz C. N Y State J Med. 1974 May;74(5):804-7. N Y State J Med. 1974. PMID: 4208486 Review. No abstract available.
• [Enzyme inductors in the treatment of neonatal hyperbilirubinemia].

  Daskalova E. Daskalova E. Akush Ginekol (Sofiia). 1977;16(3):213-9. Akush Ginekol (Sofiia). 1977. PMID: 331988 Clinical Trial. Bulgarian. No abstract available.
• [Antiepileptic drugs in the newborn. Clinical and pharmacological data].

  Rating D, Nau H, Kuhnz W, Jäger-Roman E, Helge H. Rating D, et al. Monatsschr Kinderheilkd. 1983 Jan;131(1):6-12. Monatsschr Kinderheilkd. 1983. PMID: 6339881 Review. German. No abstract available.
• P henobarbital-Dilantin treatment of the intrauterine patient.

  O'Leary JA, Feldman M, Switzer HE. O'Leary JA, et al. J Reprod Med. 1970 Aug;5(2):81-3. J Reprod Med. 1970. PMID: 5521773 English. No abstract available.